Altered microtubule associated proteins in schizophrenia

NeuroQuantology

Volumn 5, Issue 1, 2007, Pages 58-61

  Benítez King, Gloria ^a   Ramírez Rodríguez, Gerardo ^a   Ortíz López, Leonardo ^a  

^a INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

Author keywords

Cytoskeletal disease; Microtubule associated proteins; Schizophrenia

Indexed keywords

CLOZAPINE; MICROTUBULE ASSOCIATED PROTEIN; NEUROLEPTIC AGENT;

COGNITIVE DEFECT; CYTOSKELETON; DENDRITE; DENDRITIC SPINE; DRUG TARGETING; HUMAN; NERVE FIBER; NONHUMAN; REVIEW; SCHIZOPHRENIA; SYNAPSE;

EID: 54949111727     PISSN: None     EISSN: 13035150     Source Type: Journal    
DOI: 10.14704/nq.2007.5.1.117     Document Type: Review

References (13)

1. Arnold SE, Lee VM, Gur RE, Trojanowski JQ. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci U S A. 1991;88:10850-10854.
2. Benítez-King G, Ramirez-Rodríguez G, Ortiz L, Meza I. The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia. Curr Drug Targets CNS Neurol Disord 2004;3:515-533.
3. Bosc C, Andrieux A, Job D. STOP proteins. Biochemistry 2003;42:12125-12132.
4. Cotter D, Kerwin R, Doshi B, Martin CS, Everall IP. Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophrenia. Brain Res 1997;765:238-246.
5. Dwork AJ, Rosoklija G, Jones LB. Reduced spinophilin in schizophrenia. Am J Psychiatry 2005;162:1389-1390.
6. Eastwood SL, Lyon L, George L, Andrieux A, Job D, Harrison PJ. Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice. J Psychopharmacol 2006.
7. Garey LJ, Ong WY, Patel TS, Kanani M, Davis A, Mortimer AM et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 1998;65:446-453.
8. Huerto-Delgadillo L, Antón-Tay F, Benítez-King G. Effects of melatonin on microtubule assembly depend on hormone concentration: role of melatonin as a calmodulin antagonist. J Pineal Res 1994;17:55-62.
9. Kamiya A, Kubo K, Tomoda T, Takaki M, Youn R, Ozeki Y et al. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 2005;7:1167-1178.
10. Miyoshi K, Honda A, Baba K, Taniguchi M, Oono K, Fujita T et al. Disrupted-In-Schizophrenia 1, a candidate gene for schizophrenia, participates in neurite outgrowth. Mol Psychiatry 2003;8:685-694.
11. Morris JA, Kandpal G, Ma L, Austin CP. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation. Hum Mot Genet 2003;12:1591-1608.
12. Uranova NA, Aganova EA. [Ultrastructure of the synapses of the anterior limbic cortex in schizophrenia]. Zh Nevropatol Psikhiatr lm S S Korsakova 1989;89:56-59.
13. Van Woerkom AE. The major hallucinogens and the central cytoskeleton: an association beyond coincidence? Towards sub-cellular mechanisms in schizophrenia. Med Hypotheses 1990; 31:7-15.